Product Details
Teva-Ciprofloxacin
Ciprofloxacin250 mg
Tablet
DIN/PIN/NPN
02161737
Manufacturer
Teva Canada Limited
Formulary Listing Date
2004-07-20
Unit Price
0.4454
Amount MOH Pays
0.4454
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Ciprofloxacin: Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children <18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.
ATC Code
J01MA02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02161737 | Teva-Ciprofloxacin | 0.4454 | 0.4454 |
| 02379627 | Septa-Ciprofloxacin | 0.4454 | 0.4454 |
| 02248756 | Sandoz Ciprofloxacin | 0.4454 | 0.4454 |
| 02246825 | Ratio-Ciprofloxacin | 0.4454 | 0.4454 |
| 02303728 | Ran-Ciproflox | 0.4454 | 0.4454 |
| 02248437 | PMS-Ciprofloxacin | 0.4454 | 0.4454 |
| 02423553 | Mint-Ciproflox | 0.4454 | 0.4454 |
| 02379686 | Mar-Ciprofloxacin | 0.4454 | 0.4454 |
| 02380358 | Jamp-Ciprofloxacin | 0.4454 | 0.4454 |
| 02247339 | Co Ciprofloxacin | 0.4454 | 0.4454 |
| 02386119 | Ciprofloxacin | 0.4454 | 0.4454 |
| 02353318 | Ciprofloxacin | 0.4454 | 0.4454 |
| 02155958 | Cipro | NA | NA |
| 02381907 | Auro-Ciprofloxacin | 0.4454 | 0.4454 |
| 02229521 | Apo-Ciproflox | 0.4454 | 0.4454 |